science wire

« BACK

Health



Results 351 - 400 of 18859.
« Previous 1 ... 4 5 6 7 8 9 10 11 12 ... 378 Next »


Pharmacology - Health - 17.09.2019
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis
Phase III PREVENT study met 16-week primary endpoint of ASAS40 in patients with active non-radiographic axial spondyloarthritis (nr-axSpA).

Life Sciences - Health - 16.09.2019
In human cells and mice, a cure for the common cold, Stanford-UCSF study reports
Disabling a single, apparently noncritical protein in cells may foil replication of the viruses that cause half of all common colds, polio and other diseases, according to researchers at Stanford and UCSF. Temporarily disabling a single protein inside our cells might be able to protect us from the common cold and other viral diseases, according to a study led by researchers at Stanford University and University of California-San Francisco.

Computer Science / Telecom - Health - 16.09.2019
AI to enhance manufacturing, energy, and healthcare thanks to £6.5m EPSRC grant
The grant will help scientists, engineers, and clinicians train algorithms to solve energy, manufacturing, and healthcare problems.

Environment - Health - 16.09.2019
UCL launches new campaign to celebrate its disruptive discoveries
UCL is today launching the public phase of its major new campaign #MadeAtUCL to celebrate over 100 disruptive discoveries pioneered by some of the university's leading researchers.

Health - Veterinary Science - 16.09.2019

Pharmacology - Health - 13.09.2019
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
Both ASCLEPIOS I and II studies met their primary endpoints in patients with relapsing forms of MS (RMS) ; overall ofatumumab (OMB157), a subcutaneous, potent, fully-human antibody targeting CD20 pos

Agronomy / Food Science - Health - 13.09.2019
Experts warn UK food safety at risk with public softened up for lower standards
There are signs that the government is trying to soften up the public for lower food standards post-Brexit, including imported chlorinated chicken and hormone-treated beef, a new briefing from the Food Research Collaboration has highlighted.

Pharmacology - Health - 13.09.2019
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis
Post-hoc analysis from a Phase III open-label extension study showed a 42 percent reduction in the risk of PPMS patients needing a wheelchair after 6.5 years of OCREVUS treatment compared with patients who started OCREVUS after the double-blind period Interim analysis of Phase IIIb study shows 87 percent of patients with suboptimal response to previous treatment had no evidence of disease activity one year after switching to OCREVUS Separ

Pharmacology - Health - 13.09.2019
Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer
New fixed-dose combination is administered under the skin in just minutes, significantly reducing the time spent receiving treatment Data will be submitted to health authorities around the world, inc

Psychology - Health - 12.09.2019
While modern life may exacerbate depression, it may also give us the tools to treat it
Worldwide, rates of depression increased by 15 percent between 2005 and 2015, according to the World Health Organization.

Health - Pharmacology - 12.09.2019
Pioneering data research centres to enable cutting-edge research and innovation to benefit UK patients
The University of Birmingham will play a key role in new data hubs that will enable cutting-edge research for health discoveries and aim to give patients across the UK faster access to pioneering new treatments. Led by Health Data Research UK , the hubs aim to improve the lives of people with debilitating conditions, and will link up different types of health data and make it more easily accessible and user-friendly for research, while maintaining strict controls around data privacy and consent.

Life Sciences - Health - 12.09.2019
Decoding Messages in the Body's Microscopic Metropolises
Decoding Messages in the Body’s Microscopic Metropolises
A study aimed at identifying and examining the small messenger proteins used by microbes living on and inside humans has revealed an astounding diversity of more than 4,000 families of molecules - many of which have never been described previously. The research, led by Stanford University and now published in Cell , lays the groundwork for future investigations into how the trillions of bacteria, archaea, and fungi that compose human microbiomes compete for resources, attack and co-exist with one another, and interact with our own cells.

Pharmacology - Health - 12.09.2019
Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum
Pivotal phase III SAkuraStar study shows 55% reduction in the risk of relapse for satralizumab monotherapy versus placebo presented at ECTRIMS congress 2019 74% reduction in the risk of relapse for s

Pharmacology - Health - 12.09.2019
Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy
Data will be shared with health authorities globally, including the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) Roche today announced positive data from the Phase III IM

Health - Administration - 11.09.2019
Top doctors release new guidance on how to stay fit and healthy
The UK's top doctors are recommending over-65s take up dancing, bowls or even activities like tai chi to help stave off injury and illness in old age.

Health - 11.09.2019
Support for voice-hearers goes online
Support for voice-hearers goes online
People who hear voices, their families and mental health professionals will benefit from a new information and support website based on research by Durham University.

Pharmacology - Health - 11.09.2019
FDA Phase 1 Trial Shows Hydrogel to Repair Heart Is Safe to Inject in Humans-A First
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack. The trial is the first to test a hydrogel designed to repair cardiac tissue.

Life Sciences - Health - 11.09.2019
Saving the Tasmanian devil: crowdfunded mission raises new hope
Saving the Tasmanian devil: crowdfunded mission raises new hope
Extinction once seemed inevitable for the Tasmanian devil, but on an expedition to the state's remote southwest, researchers made a discovery that could help protect the species.

Health - Event - 11.09.2019

Health - Life Sciences - 10.09.2019

Life Sciences - Health - 10.09.2019
Wyss Center and Osypka announce collaboration
Wyss Center and Osypka announce collaboration
Today the Wyss Center for Bio and Neuroengineering, Geneva, Switzerland and OSYPKA AG/OSYPKA Medtec, Rheinfelden, Germany and Longmont, Colorado, USA, announced a collaboration to develop and integrate innovative technologies into implantable neuro-devices.

Life Sciences - Health - 10.09.2019

Social Sciences - Health - 10.09.2019

Pharmacology - Health - 10.09.2019
Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS
Blood neurofilament light chain (NfL) levels were significantly lowered following OCREVUS treatment in analyses of Phase III studies in RMS and PPMS New data show NfL may be a biomarker for predicting future disability outcomes Separate analyses presented from one of the first studies to demonstrate NfL levels are correlated with active MRI lesions in PPMS Roche today announced new data from OCREVUS (ocrelizumab) trials in relapsing and primary progressive multiple sclerosis (MS).

Health - Life Sciences - 09.09.2019
Tiny capsules packed with gene-editing tools offer alternative to viral delivery of gene therapy
New tools for editing genetic code offer hope for new treatments for inherited diseases, some cancers, and even stubborn viral infections. But the typical method for delivering gene therapies to specific tissues in the body can be complicated and may cause troubling side effects. Researchers at the University of Wisconsin-Madison have addressed many of those problems by packing a gene-editing payload into a tiny, customizable, synthetic nanocapsule.

Pharmacology - Health - 09.09.2019
Novartis data confirm long-term efficacy and safety of Aimovig for majority of patients with episodic migraine
The 5-year open-label treatment period (OLTP) examines sustained efficacy and long-term safety of Aimovig (erenumab) in patients with episodic migraine, starting on 70mg and switched after two years

Pharmacology - Health - 09.09.2019
Validates guidelines on treating patients with an underactive thyroid
A study led by the University of Birmingham provides strong support for current recommendations on treating patients with an underactive thyroid and validates latest UK and US guidelines, say researchers. The retrospective cohort study , published in The BMJ , analysed anonymous GP records of over 162,000 patients who have been diagnosed with hypothyroidism - a highly prevalent condition more commonly known as an underactive thyroid.

Health - Mechanical Engineering - 09.09.2019

Health - 09.09.2019
Glass down, FASD awareness turned up
Most Australians know it is unsafe to drink during pregnancy, but researchers say the number of children with lifelong impacts from Fetal Alcohol Spectrum Disorder (FASD) remains far too high.

Health - 07.09.2019
Researchers lead new national guidance on how to stay fit and healthy
Researchers lead new national guidance on how to stay fit and healthy
Guidance on how the UK population can stay fit and healthy has been updated thanks to a major review led by the University of Bristol. The physical activity guidelines issued today by the four Chief Medical Officers (CMOs) of England, Scotland, Wales and Northern Ireland, offer advice to all age groups and - for the first time - pregnant women, new mums and disabled adults.

Pharmacology - Health - 06.09.2019
European Commission approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of people with extensive-stage small cell lung cancer
Tecentriq in combination with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy approved by the European Medicines Agency for the initial treatment of extensive-stag

Health - 05.09.2019
Vontobel Award: Systematic Remembering and Similar Surgical Consequences
This year's Vontobel Award for Research on Age(ing) goes to Burcu Demiray Batur from the University of Zurich, Jonathan Rychen from the University Hospital of Basel and Sarah Stricker from the Hôpital Necker in Paris.

Innovation - Health - 04.09.2019
UCLA and Theseus AI announce license agreement for technology that interprets spine MRIs
UCLA signed a license agreement with Theseus AI for technology developed at UCLA that uses artificial intelligence to interpret MRI scans of patients' spines.

Pharmacology - Health - 04.09.2019
Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS
Investigational medicine satralizumab significantly reduces the risk of relapse in pivotal SAkuraStar monotherapy study for neuromyelitis optica spectrum disorder New data provide insights into neuro

Health - Physics - 03.09.2019
EU Funding for Research at TUM
EU Funding for Research at TUM
The European Research Council (ERC) has announced that seven of its ERC Starting Grants will be awarded to scientists at the Technical University of Munich (TUM) this year.

Health - Pharmacology - 03.09.2019
Poor diet can lead to blindness
An extreme case of "fussy" or "picky" eating caused a young patient's blindness, according to a new case report published today [2 Sep 2019] in Annals of Internal Medicine.

Environment - Health - 03.09.2019
Poverty as a disease trap
Poverty as a disease trap
The realities of subsistence living in a region of Senegal hard hit by schistosomiasis make reinfection likely, despite mass drug administration. Stanford researchers find that engaging communities in the design of disease control programs could help. No drug can cure a paradox. That basic truth is at the heart of a new Stanford-led study highlighting how poverty traps make it impossible to eradicate a potentially deadly disease with current approaches.

Pharmacology - Health - 02.09.2019
Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings
Results from PROVE-HF trial show significant improvements in measures of cardiac structure and function at six months and one year in heart failure with reduced ejection fraction (HFrEF) patients ; EVALUATE-HF results complement findings   PROVE-HF establishes significant correlation between improvement in widely used cardiac biomarker and positive changes in heart structure and ability to pump blood in patients taking Entresto   Safety and tole

Health - Innovation - 02.09.2019
Preventing asthma attacks: a father's fight for his daughter
Preventing asthma attacks: a father’s fight for his daughter
An asthma attack took Thea Notaras' life two weeks before her 17th birthday. Now her father is working to save others from her fate.

Health - Pharmacology - 02.09.2019
Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86%
BLOCKSTONE study reaches primary endpoint of fewer people testing positive for flu, with fever and at least one respiratory symptom, when treated with Xofluza versus placebo Xofluza may represent an
« Previous 1 ... 4 5 6 7 8 9 10 11 12 ... 378 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |